Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT).

NCT00232674 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00232674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT).
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
July 31, 1999
Completion date
February 29, 2004
Enrollment
240
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease